IV Corticosteroids for Hospitalized Patients with Asthma Exacerbation

Primary Treatment Components

Systemic corticosteroids are a cornerstone of asthma exacerbation treatment and should be administered early as they are the only treatment effective for the inflammatory component of asthma 1, 2
The anti-inflammatory effects of corticosteroids may not be apparent for 6-12 hours after administration, making early administration critical 1
Primary treatment for all asthma exacerbations includes oxygen to maintain SaO₂ >90%, or >95% in pregnant women and patients with heart disease, inhaled short-acting β₂-agonists, and systemic corticosteroids 2

For adults, the American College of Allergy, Asthma, and Immunology recommends 40-80 mg/day of prednisone in 1 or 2 divided doses until peak expiratory flow reaches 70% of predicted or personal best 3, 4
For children, the American Academy of Pediatrics recommends 1-2 mg/kg/day in 2 divided doses, with a maximum of 60 mg/day, until peak expiratory flow is 70% of predicted or personal best 3, 4

Oral administration of prednisone has effects equivalent to intravenous methylprednisolone but is less invasive, as stated by the American College of Allergy, Asthma, and Immunology 2

The total course of systemic corticosteroids for an asthma exacerbation requiring hospitalization may last from 3 to 10 days, according to the American College of Allergy, Asthma, and Immunology 3, 4
For corticosteroid courses of less than 1 week, there is no need to taper the dose, as recommended by the American College of Allergy, Asthma, and Immunology 3

Inhaled ipratropium bromide should be added to β₂-agonist therapy in severe exacerbations to increase bronchodilation, as suggested by the American College of Allergy, Asthma, and Immunology 2
IV magnesium sulfate can moderately improve pulmonary function in patients with severe refractory asthma, according to the American Heart Association 1

Patients should receive oral prednisone for 1-3 weeks, as recommended by the American College of Allergy, Asthma, and Immunology, although this fact is from Praxis Medical Insights, an alternative source is not available 5

Inhaled corticosteroids provide no additional benefit during acute exacerbations when systemic corticosteroids have already been administered, as stated by the American Academy of Allergy, Asthma, and Immunology 6
Montelukast, a leukotriene modifier, has no established role in the acute management of severe asthma exacerbations and is not mentioned in any major guidelines for emergency treatment, according to the American Academy of Allergy, Asthma, and Immunology 6, 7

The timing of magnesium administration matters, and patients should be reassessed 15-30 minutes after initial treatment before adding magnesium, as recommended by the American College of Chest Physicians and the British Thoracic Society 6, 8
Patients receiving magnesium should be monitored for ICU transfer if they show deteriorating peak flow, worsening hypoxia, exhaustion, confusion, or altered mental status despite magnesium, as advised by the American College of Chest Physicians and the British Thoracic Society 6, 8